Hexamethylenebisacetamide (HMBA) is a potent inducer of murine erythroleukemia (MEL) cell differentiation. The mechanism of action of HMBA is not known. In this study we provide evidence that protein kinase C has a role in inducer-mediated MEL cell differentiation: (i) HMBA induces the formation of a soluble, proteolytically activated form of protein kinase C that is catalytically active in the absence of Ca2' and phospholipid; (it) the protease inhibitor leupeptin blocks formation of this activated form of the kinase and inhibits HMBA-induced MEL cell hemoglobin accumulation; (iiW) phorbol 12-myristate 13-acetate (PMA) inhibits HMBAinduced MEL differentiation and causes depletion of total protein kinase C activity; (iv) MEL cells depleted in protein kinase C activity by culture with PMA are resistant to induction by HMBA; (v) upon removal of PMA, restoration of MEL cell sensitivity to HMBA is correlated with reaccumulation of protein kinase C activity; and (vW) MEL cells grown to density arrest are both depleted of protein kinase C activity and resistant to HMBA. Together, these results suggest that HMBA-mediated MEL cell differentiation involves a protein kinase C-related mechanism and the proteolytically activated form of the kinase, which does not require Ca2+ or phospholipid for its catalytic activity.
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Induction of murine erythroleukemia (MEL) cells to terminal erythroid differentiation has provided a model suitable for characterizing changes in gene expression during induced terminal differentiation (1) . The mechanism by which hexamethylenebisacetamide (HMBA) induces the changes that initiate the process of terminal cell division and expression of the terminal differentiated phenotype is not known. HMBA causes a modulation in expression of genes related to the differentiated phenotype, such as the genes for the a1-and IBmaJ-globins (2) ; genes related to general metabolic functions, such as the rRNA genes (3); and genes that may have a role in regulating cell proliferation, such as the protooncogenes c-myb, c-myc, and c-fos (4) . The tumor promoter phorbol 12-myristate 13-acetate (PMA) is a potent inhibitor of HMBAinduced MEL cell differentiation (5) . A number of reports provide evidence for a role for protein kinase C (PKC) in signal transduction during cell proliferation and differentiation (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . There is evidence that tumor promoters such as TPA elicit responses through activation of PKC and that the kinase itself is a specific receptor for the tumor promoter (10) (11) (12) (13) (20) (21) (22) (23) (24) (25) .
We have examined the role of PKC in the pathway of HMBA induction. We report that induction of MEL cells by HMBA is associated with the appearance in the cytosol of a proteolytically activated form of PKC (PKM) that is catalytically active in the absence of Ca2+ and phospholipid (26) (27) (28) (29) (30) (31) . Leupeptin (32) , an inhibitor of the proteolytic enzyme calpain (33) (which can catalyze conversion of membrane-bound, native PKC to the soluble, activated PKM form of the kinase), blocks HMBA-induced MEL cell differentiation and the accumulation of PKM in the cytosolic fraction. PMA causes depletion of PKC activity in MEL cells and is associated with loss of responsiveness to HMBA. Upon removal of PMA, the reappearance of sensitivity to HMBA correlates with reaccumulation of PKC activity. Cultures of MEL cells grown to density arrest are depleted of PKC activity and resistant to HMBA. Taken together, these findings suggest that PKC and the proteolytically activated PKM form of the kinase appear to be involved in the pathway of HMBA-induced MEL cell differentiation.
METHODS
Cell Culture and Materials. MEL cells DS19 were maintained in a minimal essential medium containing 10% (vol/vol) fetal calf serum (34) . Each culture was initiated with an innoculum of 105 cells per ml in corning 75-cm2 culture flasks unless otherwise indicated. HMBA (35) was added to the cultures at a final concentration of 5 mM. Leupeptin and PMA were added at final concentrations of 0.1 mM and 100 ng/ml, respectively, unless otherwise indicated. Benzidinereactive cells and cell counts were determined as described (35) . DEAE-cellulose (type DE 52) was purchased from Whatman. [32P]ATP was obtained from Amersham. Phosphatidylserine, 1,2-diolein, histones (type III-S), and leupeptin were purchased from Sigma.
Hemoglobin Assay. Cells (1 x 107 to 2 x 107) were collected by centrifugation, washed in saline, and resuspended in 1 ml of H20. Cells were lysed by three cycles of freezing (on a dry-ice/ethanol bath) and thawing (in a water bath set to 37°C). A cytosolic fraction, collected by centrifugation at 100,000 x g for 10 min at 4°C, was assayed for total hemoglobin as follows: 0.1-0.2 ml of the cytosolic fraction was diluted to 1 ml with distilled water, 100 ,ul of freshly prepared benzidine HCl (10 mg/ml) was added, the solution was mixed, and the absorbance at 604 nm was determined; subsequently, 40 ,u of 30% H202 was added, the solution was mixed, and the increase in Aw4 was followed. Within 90 sec the absorbance reached a peak and then decreased. Hemoglobin concentration was determined by relating the peak Aw4 value (having subtracted the Aw4 value observed before the addition of peroxide) to a standard curve prepared with pure bovine hemoglobin.
Abbreviations: MEL cells, murine erythroleukemia cells; native PKC, Ca2+-and phospholipid-dependent protein kinase C; PKM, proteolytically generated form of PKC that is catalytically active in the absence of Ca2+ and phospholipid; PMA, phorbol 12-myristate 13-acetate; HMBA, hexamethylenebisacetamide.
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Preparation of Cytosolic and Membrane Fractions from MEL Cells. MEL cells (2 x 107 cells) were suspended in 2 ml of 10 mM Hepes buffer (pH 7.4) containing 0.25 M sucrose, 10 mM mercaptoethanol, and 5 mM EDTA (lysing buffer). Cells suspended in this buffer were lysed by sonication (6 strokes for 10 sec each) and then centrifuged at 100,000 x g for 10 min. The supernatant fraction was removed and used as the cytosolic fraction. The pellet was resuspended in 1 ml of the lysing buffer containing 0.2% Triton X-100 and served for the determination of membrane-associated enzyme activity.
PKC. PKC activity was assayed essentially as described (28) . Briefly, the incubation mixture (0.2 ml) contained 50 mM sodium borate (pH 7.5), 10 0Ci (1 Ci = 37 GBq) of [y-32P]ATP, 10 ,uM ATP, 5 mM MgCl2, 100 ,ug of type III-S histone, 10 pg of phosphatidylserine, 0.2 ,ug of dioleylglycerol, 1 mM Ca2+, and an appropriate amount of cytosol or solubilized membrane fraction. To assay the Ca2+-and phospholipid-independent PKC, Ca2+ and the phospholipids in the reaction mixture were replaced by 5 mM EDTA. The reaction was incubated for 10 min at 30°C and stopped by addition of 1 ml of 10% (wt/vol) trichloroacetic acid and 2 mg of bovine serum albumin. The precipitate was collected by filtration on a 25-mm glass-fiber filter, and radioactivity was assayed in scintillation fluid. One unit of PKC activity was defined as the amount that causes the incorporation of 1 nmol of 32p per min into histone under these conditions.
Partial Purification of Different Forms of PKC. MEL cells (2 x 107) were lysed in 2 ml of lysing buffer. The supernatant fraction was recovered after centrifugation of the cell lysate at 100,000 x g for 10 min at 4°C and loaded on a DE-52 column (1 x 7 cm) previously equilibrated with 10 mM Hepes buffer containing 10 mM mercaptoethanol and 5 mM EDTA. At a flow rate of 0.5 ml/min, fractions of 1 ml were collected. The column was washed with 5 volumes of the same buffer and then eluted with a linear gradient of 0-0.3 M NaCl (50 + 50 ml). The Ca2+ and phospholipid PKC activity was recovered in fractions [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] (Fig. 1A) . After 5 hr in culture with HMBA, the level of native PKC activity decreased by -20% or by 1 unit/mg of protein and continued to decrease at a slower rate during the ensuing period of culture (Fig. 1B) . By 48 hr, native PKC activity decreased to =55% of that in uninduced cells. During culture with HMBA, the PKM form appeared in the cytosol, reaching levels as high as 1.0 unit/mg of protein within 2 hr. The appearance of PKM in HMBAtreated MEL cells is similar to that which occurs during activation of human neutrophils (16, 29) . During culture with HMBA, there was a loss of total PKC activity (the sum of native PKC plus PKM activity), which amounted to -30% of the initial activity.
Effect of Leupeptin on MEL Cells Cultured with HMBA. It has been established that the proteolytic enzyme calpain converts membrane-associated native PKC to an activated PKM form in the cytosol that does not require Ca2+ or phospholipids for its catalytic activity (16, (28) (29) (30) . Calpainmediated proteolytic activation of PKC could be demonstrated in membrane preparations of MEL cells (S.P. and E.M., unpublished observations). We examined the effect of the proteolytic enzyme inhibitor leupeptin (32, 33) MEL cells cultured with HMBA and PMA, there was inhibition of inducer-mediated hemoglobin accumulation ( Fig. 2A) . Within 30 min in the presence of both HMBA and PMA there was an increase in membrane-associated native PKC activity that then decreased to undetectable levels by 2-4 hr (Fig. 2C ), while total PKC activity decreased by >90% within 2 hr (Fig. 2B) .
To test whether PKC activity has a role in HMBA-induced differentiation, MEL cells were depleted of PKC activity by culture with PMA. MEL cells cultured with PMA for 3 hr showed a decrease in total PKC activity to undetectable levels (Fig. 3) . PKC-depleted MEL cells were transferred to fresh medium without additions, and culture was continued for up to 70 hr. Aliquots of these MEL cells were removed at zero time (that is, after 3 hr of preculture with PMA) and at 15, 24, 40 , and 70 hr of culture in medium without HMBA or PMA. The cells recovered by centrifugation from these aliquots were resuspended in fresh medium with HMBA and cultured for an additional 36 hr, at which time the cells were recovered and assayed for hemoglobin content and total PKC activity (Fig. 3) . PKC-depleted MEL cells were resistant to induction of hemoglobin by HMBA during the initial 24 hr, (Fig. 3) .
PKC Activity in Relation to MEL Cell Growth and HMBA Inducibility. We have previously demonstrated that as MEL cells grow in culture and increase in density from an initial concentration of 0.1 x 106 cells per ml to 2-3 x 106 cells per ml, there is a loss in sensitivity to HMBA (39) . Under the present conditions of culture, MEL cells reached approximately constant density at 2-3 x 106 cells per ml. Transfer of cells from a density-arrested culture to fresh medium at an initial concentration of 0.1 x 106 cells per ml was associated with restoration of cell growth and HMBA inducibility. To further examine the relationship between MEL cell inducibility to HMBA and PKC activity, the effect of cell growth on sensitivity to the inducer and on the level of kinase activity was determined. MEL cells were cultured at an initial density of 0.1 x 106 cells per ml without HMBA; at various times, aliquots of the culture were removed to determine cell density, total PKC activity, and HMBA induction of hemoglobin accumulation ( pathway of certain HMBA-induced changes that occur during MEL cell terminal differentiation. Earlier studies showed that polar-planar compounds such as dimethyl sulfoxide, which can induce MEL cell differentiation, cause a decrease in levels of phosphatidylinositol metabolities, including inositol trisphosphate and diacylglycerol, within 2 hr of onset of culture (40) . Diacylglycerol activates native PKC (41) and inhibits dimethyl sulfoxideinduced differentiation (42) . We have reported that PMA inhibits HMBA-induced MEL cell differentiation (5, 43) . In the present studies, we show that PMA causes a transient increase in membrane-associated native PKC activity, followed by a marked depletion in total PKC activity. In addition, depletion of PKC activity occurs in MEL cells allowed to grow to density arrest. MEL cells depleted of PKC activity under either condition are resistant to HMBA.
HMBA rapidly induces accumulation of the proteolytically generated PKM form of the kinase found in the cytosol. Leupeptin is an inhibitor of proteolytic enzymes, such as calpain, which catalyzes limited proteolysis of membranebound PKC to yield the active PKM fragment in the cytosol (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . Leupeptin was shown to inhibit, at least transiently, the HMBA-induced accumulation of hemoglobin and the accumulation of PKM activity in the cytosol. Taken together, these observations indicate that certain effects of HMBA that lead to MEL cell terminal differentiation may be mediated via a PKC pathway involving proteolytically generated PKM or other small peptides (18, 24) . PKC activity, and in particular the cytosolic PKM form of the kinase, may be involved in HMBA-mediated modulation of gene expression (6, 17, 18) .
HMBA-mediated MEL cell differentiation is a multistep process (34) . For example, among the early changes occurring within 1-4 hr of culture with HMBA is a decrease in expression of c-myb and c-myc genes (4). This early decrease in transcription of these genes is not blocked by cycloheximide and could reflect alterations in the state of phosphorylation of proteins that are involved in regulating expression of these genes. With continued culture with HMBA, MEL cells become irreversibly committed to terminal erythroid differentiation, and it has been shown that changes in chromatin structure are involved in the inducer-mediated alterations in gene expression that characterize this process (1) (2) (3) . Some of these changes in chromatin could be secondary to the inducer-mediated changes in protein kinase activity. in a uniform fashion (43) . Inducer-mediated accumulation of hemoglobin is more sensitive to inhibition by PMA than is the increase in heme synthetic enzyme activity (43) . PMA does not block the early HMBA-induced changes in c-myb and c-myc expression but does prevent commitment to terminal cell division (R. Ramsay, personal communication). Differences in the degree of suppression of the several inducermediated changes may reflect transduction of the inducer signal by more than a single pathway or by different forms of PKC (8, 31, 44, 45) .
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